Company Valuation: Healthlead

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025
Market Cap 1 4,923 6,691 2,829 2,774 1,886
Change - 35.91% -57.72% -1.92% -32.02%
Enterprise Value (EV) 1 4,332 6,205 2,495 2,554 1,655
Change - 43.25% -59.79% 2.37% -35.2%
P/E 46.9x 56.6x 37.9x 35.4x 24.8x
PBR 5.69x 7.1x 2.92x 2.76x 1.95x
PEG 2.3x 4.5x -1x 7.37x 31.41x
Capitalization / Revenue 4.05x 4.35x 1.7x 1.38x 0.83x
EV / Revenue 3.56x 4.03x 1.5x 1.27x 0.73x
EV / EBITDA 37x 38.1x 19.8x 19.5x 10.8x
EV / EBIT 42.2x 41.8x 24.8x 26.8x 15x
EV / FCF 87.9x -737x -156x 830x 11.7x
FCF Yield 1.14% -0.14% -0.64% 0.12% 8.55%
Dividend per Share 2 0.28 0.18 0.15 0.17 0.22
Rate of return 1.55% 0.73% 1.44% 1.67% 3.06%
EPS 2 0.3861 0.4347 0.2746 0.2877 0.29
Distribution rate 72.5% 41.4% 54.6% 59.1% 75.9%
Net sales 1 1,216 1,538 1,659 2,011 2,270
EBITDA 1 117.1 163 126.3 131.3 153.5
EBIT 1 102.6 148.4 100.7 95.39 110.6
Net income 1 79.66 118.2 74.68 78.26 77.86
Net Debt 1 -591.5 -486 -333.6 -220.1 -230.9
Reference price 2 18.100 24.600 10.400 10.200 7.200
Nbr of stocks (in thousands) 272,000 272,000 272,000 272,000 261,956
Announcement Date 25/2/22 27/2/23 28/2/24 28/2/25 25/2/26
1THB in Million2THB
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 35.82M
16.9x0.69x10.23x-.--% 15.05B
16.63x0.75x7.79x2.24% 6.37B
20.35x0.77x12.91x1.1% 6.3B
14.54x0.89x6.15x2.91% 4.09B
14.41x1.24x7.57x5.58% 3.21B
13.87x0.58x4.51x5.21% 3.06B
13.95x0.84x6.3x4.62% 2.95B
31.8x - - - 2.47B
Average 17.81x 0.82x 7.92x 3.09% 4.84B
Weighted average by Cap. 17.39x 0.77x 8.94x 1.96%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. HL Stock
  4. Valuation Healthlead